跳至主要内容
临床试验/NCT00018824
NCT00018824已完成4 期

The Treatment of Late Life Major Depression Complication by Alcohol

US Department of Veterans Affairs1 个研究点 分布在 1 个国家目标入组 74 人开始时间: 1999年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
74
试验地点
1
主要终点
Alcohol use'

研究概览

简要总结

The purpose of this study is to test the efficacy combining a treatment for depression with a treatment for alcohol dependence.

详细描述

This study aims to study 80 patients with comorbid alcohol dependence and a depressive syndrome. After appropriate detoxification, patients are started on either naltrexone 50 mg or placebo. After one week, sertraline is added in an open label fashion. It is hypothesized that those patients receiving combination therapy will last 3 months with follow-up tracking lasting 1 year.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
55 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 55
  • Current depressive syndrome
  • Current alcohol dependence
  • No psychosis
  • No opioid or cocaine abuse or dependence

排除标准

  • 未提供

研究组 & 干预措施

1

Experimental

Naltrexone

干预措施: NALTREXONE (Drug)

2

Placebo Comparator

Placebo

干预措施: Placebo (Drug)

结局指标

主要结局

Alcohol use'

时间窗: 12 weeks

次要结局

未报告次要终点

研究者

申办方类型
Fed

研究点 (1)

Loading locations...

相似试验

Treating Alcohol Use In Older Adults With Depression | 临床试验